News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Nycomed Amersham PLC Gets Nycomed Trademark Payment
October 25, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WATERTOWN, Mass. (AP) -- Specialty drug maker Acusphere Inc. said Monday that it received accelerated license fees from Nycomed Danmark APS to trademark the ultrasound contrast agent AI-700.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Earnings
Regeneron basks in first gene therapy approval as Dupixent, Eylea carry robust Q1 earnings
April 29, 2026
·
3 min read
·
Heather McKenzie
Alzheimer’s disease
Biogen ready to catch Alzheimer’s patients transitioning off Lilly’s Kisunla
April 29, 2026
·
3 min read
·
Annalee Armstrong
Mergers & acquisitions
Chiesi snaps up KalVista for $1.9B, betting big on rare disease med Ekterly
April 29, 2026
·
2 min read
·
Gabrielle Masson
Earnings
AstraZeneca bullish on $80B sales goal after beating expectations, Phase 3 data wins
April 29, 2026
·
2 min read
·
Nick Paul Taylor